MBX Biosciences, Inc.

8-K Director or officer change Jul 13, 2026 8-K Regulation FD disclosure; Other events Jun 12, 2026 8-K Director or officer change; Shareholder vote results Jun 5, 2026 8-K Regulation FD disclosure; Other events May 11, 2026 8-K Results of operations (earnings release) May 7, 2026 10-Q Quarter ended 2026-03-31 May 7, 2026 10-K Fiscal year ended 2025-12-31 Mar 12, 2026 8-K Results of operations (earnings release) Mar 12, 2026 8-K Regulation FD disclosure; Other events Mar 9, 2026 8-K Entered a material agreement; Director or officer change Feb 27, 2026 8-K Other events Feb 5, 2026 8-K Director or officer change; Regulation FD disclosure Jan 22, 2026 8-K Results of operations (earnings release); Regulation FD disclosure; Other events Jan 12, 2026 10-Q Quarter ended 2025-09-30 Nov 6, 2025 8-K Results of operations (earnings release); Director or officer change Nov 6, 2025 8-K Entered a material agreement Sep 26, 2025 8-K Regulation FD disclosure; Other events Sep 22, 2025 8-K Regulation FD disclosure; Other events Sep 4, 2025 10-Q Quarter ended 2025-06-30 Aug 7, 2025 8-K Results of operations (earnings release) Aug 7, 2025 8-K Regulation FD disclosure; Other events Jun 16, 2025 8-K Regulation FD disclosure Jun 9, 2025 8-K Director or officer change; Shareholder vote results Jun 6, 2025 10-Q Quarter ended 2025-03-31 May 12, 2025 8-K Results of operations (earnings release) May 12, 2025 8-K Director or officer change; Regulation FD disclosure Apr 7, 2025 10-K Fiscal year ended 2024-12-31 Mar 17, 2025 8-K Results of operations (earnings release) Mar 17, 2025 8-K Results of operations (earnings release); Regulation FD disclosure; Other events Jan 7, 2025 10-Q Quarter ended 2024-09-30 Nov 7, 2024 8-K Results of operations (earnings release) Nov 7, 2024 8-K Amended charter or bylaws Sep 16, 2024 SCHEDULE 13G Jul 29, 2026 SCHEDULE 13G/A Jul 8, 2026 SCHEDULE 13G/A Jul 8, 2026 SCHEDULE 13G Jun 24, 2026 144 Jun 10, 2026 144 Jun 9, 2026 4 Jun 5, 2026 4 Jun 5, 2026